European society of gynecology (ESG) position paper on the proposed terminology change from PCOS … — Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2026)

Identificação

• PMID: 42367168
• DOI: 10.1080/09513590.2026.2695512
• Autores: Camil Castelo-Branco, Svetlana Vujovic, Alessandro D Genazzani, Mark Brincat, Blazej Meczekalski, Petra Stute
• Revista: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Resumo clínico (PT)

Resumo em português pendente de revisão editorial. Configure OPENAI_API_KEY para geração automática ou edite manualmente.

Abstract (original)

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder whose terminology inadequately reflects its systemic nature. The proposed renaming to polyendocrine metabolic ovary syndrome (PMOS) aims to better represent its pathophysiology. To present the European Society of Gynaecology (ESG) position regarding the proposed terminology change and its implementation. Expert consensus and narrative synthesis of current scientific evidence and international recommendations. ESG supports a structured, patient-centered transition strategy. Recommendations include prioritizing patient communication, implementing a gradual transition with prolonged dual terminology use, and integrating the new terminology systematically into scientific and educational frameworks. The importance of interdisciplinary clarity and the central role of gynecological endocrinology are emphasized. A phased and clearly communicated transition will enhance conceptual accuracy while preserving patient understanding, continuity of care, and clinical coordination. PCOS terminology inadequately reflects its endocrine–metabolic nature.ESG supports transition to PMOS through a phased, patient-centered approach.Dual terminology (‘PMOS, formerly known as PCOS’) should be maintained long-term.Systematic integration into guidelines and education is recommended.Gynecological endocrinology remains central in patient management.